Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience.
Innocenti I, Quaranta T, Tomasso A, Mosca A, Benintende G, Fresa A, Larocca LM, Stirparo L, Iadevaia F, Vuono F, Bellesi S, Bakacs A, Efremov D, Gattei V, Giannarelli D, Autore F, Laurenti L. Innocenti I, et al. Among authors: gattei v. Hematol Oncol. 2025 Jan;43(1):e70028. doi: 10.1002/hon.70028. Hematol Oncol. 2025. PMID: 39729577 No abstract available.
Measurable residual disease in chronic lymphocytic leukemia.
Benintende G, Pozzo F, Innocenti I, Autore F, Fresa A, D'Arena G, Gattei V, Lurenti L. Benintende G, et al. Among authors: gattei v. Front Oncol. 2023 Feb 14;13:1112616. doi: 10.3389/fonc.2023.1112616. eCollection 2023. Front Oncol. 2023. PMID: 36865804 Free PMC article. Review.
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study.
Benintende G, Innocenti I, Fresa A, Autore F, Tomasso A, Piciocchi A, Vuono F, Stirparo L, Mosca A, Bacigalupo A, Gattei V, Efremov D, Sangiorgi E, Laurenti L. Benintende G, et al. Among authors: gattei v. Haematologica. 2023 Aug 1;108(8):2240-2243. doi: 10.3324/haematol.2022.282268. Haematologica. 2023. PMID: 36546426 Free PMC article. No abstract available.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Autore F, Innocenti I, Reda G, Visentin A, Vitale C, Piciocchi A, Fresa A, Leone MMA, Farina L, Quaresmini G, Baratè C, Giordano A, Ferrari A, Angeletti I, De Paolis MR, Malerba L, Chiurazzi F, Loseto G, Catania G, Sportoletti P, Scortechini I, Moia R, Gentile M, Rigolin GM, Mattiello V, Gattei V, Coscia M, Trentin L, Foà R, Cuneo A, Laurenti L. Autore F, et al. Among authors: gattei v. Hematol Oncol. 2023 Dec;41(5):877-883. doi: 10.1002/hon.3199. Epub 2023 Jul 1. Hematol Oncol. 2023. PMID: 37392141
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Forestieri G, Terzi di Bergamo L, Deodato M, Frustaci AM, Moia R, Deambrogi C, Rasi S, Autore F, Merli M, Mattarucchi R, Fahrni G, Scarfo' L, Gussetti D, Bulian P, Zanatta A, Spina V, Bruscaggin A, Pini K, Piffaretti D, Pirosa MC, Salehi M, Marques de Almeida J, Passweg J, Cavalli F, Zucca E, Gerber B, Stussi G, Gattei V, Ghia P, Gregor M, Passamonti F, Laurenti L, Gaidano G, Tedeschi A, Rossi D, Condoluci A. Forestieri G, et al. Among authors: gattei v. Hematol Oncol. 2022 Dec;40(5):1100-1104. doi: 10.1002/hon.3032. Epub 2022 Jun 1. Hematol Oncol. 2022. PMID: 35613703 No abstract available.
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
Bulian P, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, D'Arena G, Efremov DG, Marasca R, Lauria F, Gaidano G, Gattei V, Laurenti L. Bulian P, et al. Among authors: gattei v. J Transl Med. 2012 Jan 30;10:18. doi: 10.1186/1479-5876-10-18. J Transl Med. 2012. PMID: 22289136 Free PMC article.
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V. Bomben R, et al. Among authors: gattei v. Clin Cancer Res. 2010 Jan 15;16(2):620-8. doi: 10.1158/1078-0432.CCR-09-1638. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068100
TLR9 signaling defines distinct prognostic subsets in CLL.
Efremov DG, Bomben R, Gobessi S, Gattei V. Efremov DG, et al. Among authors: gattei v. Front Biosci (Landmark Ed). 2013 Jan 1;18(1):371-86. doi: 10.2741/4108. Front Biosci (Landmark Ed). 2013. PMID: 23276930 Free article. Review.
297 results